
|Articles|September 1, 2003
LImits of cetirizine
The use of antihistamine cetirizine during the first six weeks of nevirapine-containing antiretroviral treatment does not protect against nevirapine-associated cutaneous reactions, according to the results of a controlled study.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
The “6-7” Advances for Dermatologists to Look Forward to in 2026
2
Exploring Type 2 Inflammation and Psoriasis Management at Horizons in Advanced Practice
3
Soquelitinib Phase 1 Data Show Sustained Clinical Improvement With Extended Treatment in AD
4
Quoin Targets World’s First Approval for Netherton Syndrome Therapy in Saudi Arabia
5



















